Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  NMCD. Nutrition Metabolism and Cardiovascular Diseases

• Publication date

  1999-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 10656170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.

  1998cited by this paper
• Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

  1998cited by this paper
• Hypertriglyceridemia as a cardiovascular risk factor.

  1998cited by this paper
• Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels.

  1996cited by this paper
• Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.

  1995cited by this paper
• Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.

  1995cited by this paper
• The physiological aspects of fibrinolysis.

  1994cited by this paper
• Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus.

  1993cited by this paper
• Effect of Three Fibrate Derivatives and of Two HMG-CoA Reductase Inhibitors on Plasma Fibrinogen Level in Patients with Primary Hypercholesterolemia

  1993cited by this paper
• Hypertriglyceridemia and regulation of fibrinolytic activity.

  1992cited by this paper
• Gemfibrozil Reduces Plasma Prothrombin Fragment F1+2 Concentration, a Marker of Coagulability, in Patients with Coronary Heart Disease

  1992cited by this paper
• Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men.

  1992cited by this paper
• Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

  1992cited by this paper
• A Comparison of Commercial Kits for the Measurement of Lipoprotein(a)

  1991cited by this paper
• Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.

  1991cited by this paper
• Reference values of hemostasis related factors of healthy Japanese adults. I: Circadian fluctuation.

  1990cited by this paper
• Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects.

  1990cited by this paper
• Effects of Gemfibrozil on Lipids and Haemostasis after Myocardial Infarction

  1990cited by this paper
• Serum triglyceride responses to fatty meals: effects of meal fat content.

  1988cited by this paper
• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

  1988cited by this paper
• Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke.

  1988cited by this paper
• High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

  1987cited by this paper
• Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia.

  1983cited by this paper
• An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease

  1983cited by this paper
• Atherogenesis: a postprandial phenomenon.

  1979cited by this paper
• Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

  1977cited by this paper
• Heparin cofactor activity measured with an amidolytic method.

  1975cited by this paper
• RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS.

  1964cited by this paper
• Alimentary Lipaemia in Men with Coronary Artery Disease and in Controls

  1956cited by this paper

• Fundamental Toxicological Sciences

  2019cites this paper
• Hesperidin Lowers Serum Triglyceride Level in Hypertriglyceridemic Subjects through the Improvement of VeTy Low-Density Lipoprotein Metabolic Abnormality

  2018cites this paper
• Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials

  2017influential citation
• Gemfibrozil Improves Postprandial Hypertriglyceridemia in Patients with Isolated Low HDL

  2011cites this paper
• Therapeutic Effects of Fibrates in Postprandial Lipemia

  2008cites this paper
• Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others

  2007cites this paper
• Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.

  2007cites this paper
• The effect of statins on postprandial lipemia.

  2007cites this paper
• Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality.

  2005cites this paper
• Endothelial function and postprandial lipemia.

  2004cites this paper
• An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.

  2003cites this paper
• Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease.

  2003cites this paper
• The statins: multifunctional antithrombotic and antineoplastic drugs.

  2003cites this paper
• The Statins: Multifunctional Antithrombotic and Antineoplastic Drugs

  2003cites this paper
• Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease

  2003cites this paper
• Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.

  2003cites this paper
• Lipid-independent effects of an estrogen–statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor-1 in human endothelial cell cultures

  2001cites this paper
• Nutrition and metabolism.

  2001cites this paper
• Hypertriglyceridemia

  2001cites this paper
• Prevention of a First Myocardial Infarction

  2001cites this paper
• Effect of an estrogen/statin combination on biochemical markers of endothelial function in human coronary artery cell cultures

  2001cites this paper